WuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year
WuXi Biologics (2269.HK) has been named to the 2024 Dow Jones Sustainability Indices (DJSI) for the second consecutive year, receiving top scores for its sustainable development achievements. The DJSI World represents the top 10% of 2,500 largest companies in the S&P Global Broad Market Index, based on ESG performance.
As a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), WuXi Biologics has garnered several sustainability recognitions, including:
- Inclusion in UNGC 20 Case Examples of Sustainable Development
- AAA rating from MSCI ESG Ratings for two consecutive years
- Platinum Medal from EcoVadis
- Industry and Regional Top-Rated Company by Sustainalytics
- CDP Water Security 'A list' and 'A-' Climate Change score
- Selection as FTSE4Good Index Series Constituent
- Inclusion in Hang Seng ESG 50 Index
WuXi Biologics (2269.HK) è stata nominata ai Dow Jones Sustainability Indices (DJSI) per il secondo anno consecutivo, ricevendo punteggi elevati per i suoi risultati nello sviluppo sostenibile. Il DJSI World rappresenta il 10% migliore delle 2.500 più grandi aziende dell'S&P Global Broad Market Index, basato sulle performance ESG.
Come organizzazione globale leader nella Ricerca, Sviluppo e Produzione a Contratto (CRDMO), WuXi Biologics ha ottenuto diversi riconoscimenti per la sostenibilità, tra cui:
- Inclusione negli esempi di sviluppo sostenibile dell'UNGC 20 Case
- Rating AAA da MSCI ESG Ratings per due anni consecutivi
- Medaglia di Platino da EcoVadis
- Società con valutazione top nel settore e regionale da Sustainalytics
- Lista 'A' per la Sicurezza Idrica di CDP e punteggio 'A-' per i cambiamenti climatici
- Selezione come membro dell'FTSE4Good Index Series
- Inclusione nell'Hang Seng ESG 50 Index
WuXi Biologics (2269.HK) ha sido nombrada en los Dow Jones Sustainability Indices (DJSI) por segundo año consecutivo, recibiendo altas calificaciones por sus logros en desarrollo sostenible. El DJSI World representa el 10% superior de las 2,500 empresas más grandes en el S&P Global Broad Market Index, basado en el rendimiento ESG.
Como organización líder global en Investigación, Desarrollo y Fabricación por Contrato (CRDMO), WuXi Biologics ha recibido varios reconocimientos por sostenibilidad, incluyendo:
- Inclusión en los 20 Ejemplos de Desarrollo Sostenible de UNGC
- Calificación AAA de MSCI ESG Ratings por dos años consecutivos
- Medalla de Platino de EcoVadis
- Compañía con mejor calificación en la industria y regional por Sustainalytics
- Lista 'A' de Seguridad Hídrica de CDP y puntuación 'A-' en Cambio Climático
- Selección como componente del FTSE4Good Index Series
- Inclusión en el Hang Seng ESG 50 Index
우쉬 생물학 (2269.HK)은 다우 존스 지속 가능성 지수(DJSI)에 2년 연속으로 이름을 올리며 지속 가능한 개발 성과에 대해 높은 점수를 받았습니다. DJSI 월드는 ESG 성과를 기반으로 S&P 글로벌 광범위 시장 지수에 포함된 2,500개의 가장 큰 기업 중 상위 10%를 나타냅니다.
글로벌 계약 연구, 개발 및 제조 기구(CRDMO)의 선두주자인 우쉬 생물학은 여러 가지 지속 가능성 인정을 받았습니다. 이에는 다음이 포함됩니다:
- UNGC 20개 사례의 지속 가능한 개발 예시로 포함
- MSCI ESG 평가에서 2년 연속 AAA 등급
- EcoVadis로부터 플래티넘 메달
- Sustainalytics의 산업 및 지역 최고 평가 기업
- CDP 수자원 보안 'A리스트' 및 'A-' 기후 변화 점수
- FTSE4Good 지수 시리즈 구성 요소로 선정
- 항생 ESG 50 지수에 포함
WuXi Biologics (2269.HK) a été nommé aux Indices de Durabilité Dow Jones (DJSI) pour la deuxième année consécutive, recevant les meilleures notes pour ses réalisations en matière de développement durable. Le DJSI World représente le 10 % des 2 500 plus grandes entreprises de l'indice boursier S&P Global Broad Market, basé sur la performance ESG.
En tant qu'organisation mondiale leader en recherche, développement et fabrication pour contrat (CRDMO), WuXi Biologics a obtenu plusieurs distinctions en matière de durabilité, notamment :
- Inclusion dans les 20 exemples de développement durable de l'UNGC
- Note AAA de MSCI ESG Ratings pendant deux années consécutives
- Médaille d'or d'EcoVadis
- Entreprise la mieux notée dans son secteur et au niveau régional par Sustainalytics
- Liste 'A' de la sécurité de l'eau CDP et score 'A-' pour le changement climatique
- Sélection comme constituant de la série d'indices FTSE4Good
- Inclusion dans l'indice Hang Seng ESG 50
WuXi Biologics (2269.HK) wurde zum zweiten Mal in Folge in die Dow Jones Sustainability Indices (DJSI) aufgenommen und erhielt die höchsten Bewertungen für ihre Erfolge in der nachhaltigen Entwicklung. Der DJSI World repräsentiert die besten 10 % der 2.500 größten Unternehmen im S&P Global Broad Market Index, basierend auf der ESG-Performance.
Als führendes globales Auftragsforschungs-, Entwicklungs- und Fertigungsunternehmen (CRDMO) hat WuXi Biologics mehrere Nachhaltigkeitsauszeichnungen erhalten, darunter:
- Einbindung in die 20 Fallstudien für nachhaltige Entwicklung der UNGC
- AAA-Bewertung von MSCI ESG Ratings für zwei Jahre in Folge
- Platinmedaille von EcoVadis
- Branchen- und regional am besten bewertetes Unternehmen von Sustainalytics
- CDP Wasser-Sicherheits 'A-Liste' und 'A-' Klimawandel-Score
- Auswahl als Bestandteil der FTSE4Good Index-Serie
- Einbindung in den Hang Seng ESG 50 Index
- None.
- None.
- Named for second consecutive year named to prestigious DJSI list
- Leading green biologics solutions for a healthier future
The DJSI are a family of best-in-class benchmarks for investors who have recognized that sustainable business practices are critical to generating long-term shareholder value and wish to reflect their sustainability convictions in their investment portfolios. The family of indices was launched in 1999 as the first global sustainability benchmark, and among them, DJSI World represents the top
Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, "We are honored to be included in the DJSI list for the second consecutive year. It is a reflection of and recognition for our continuous commitment to enhancing sustainability capabilities. As a global leader in Green CRDMO, we continuously deliver our own ESG excellence, while remaining dedicated to enabling global partners with end-to-end solutions driven by innovation. Going forward, we will keep pushing industry boundaries, jointly working with all our stakeholders to promote responsible practices throughout the whole value chain."
Over the past several years, WuXi Biologics has earned a number of recognitions for its significant progress in pursuing sustainable development. The company was included in UNGC 20 Case Examples of Sustainable Development for 20 Years Collection for its global leading green biologics solutions. In addition, it was granted an AAA rating from MSCI ESG Ratings for two consecutive years; awarded the distinguished Platinum Medal by EcoVadis; recognized as an Industry and Regional Top-Rated Company by Sustainalytics; named to the CDP Water Security "A list" and awarded an "A-" CDP Climate Change score; selected as a Constituent of the FTSE4Good Index Series; and included in the Hang Seng ESG 50 Index.
About WuXi Biologics
WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide.
With over 12,000 skilled employees in
WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean-energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, enhancing our commitment to sustainability.
For more information about WuXi Biologics, please visit: www.wuxibiologics.com.
Contacts
Media
PR@wuxibiologics.com
View original content:https://www.prnewswire.com/news-releases/wuxi-biologics-ranks-top-in-2024-dow-jones-sustainability-indices-for-second-consecutive-year-302341133.html
SOURCE WuXi Biologics
FAQ
What ESG achievements did WuXi Biologics (2269.HK) receive in 2024?
How does WuXi Biologics rank in the DJSI World Index compared to other companies?
What sustainability ratings has WuXi Biologics received from MSCI ESG?
What environmental scores did WuXi Biologics achieve in CDP ratings?
Which major sustainability indices include WuXi Biologics as a constituent?
